Determinant factors of osteoporosis patients reported therapeutic adherence to calcium andor vitamin D supplements: A cross-sectional, observational study of postmenopausal women

Drugs and Aging

Volumn 26, Issue 10, 2009, Pages 861-869

  Sanfelix Genovés, Josée ^a   Gil Guillén, Vicente F ^b   Orozco Beltran, Domingo ^b   Giner Ruiz, Vicente ^c   Pertusa Martínez, Salvador ^d   Reig Moya, Begoña ^a   Carratalá, Concepción ^b  

^a Nazaret Health Center   (Spain)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^c Ciudad Jardíns Health Centre   (Spain)

^d Centro de Salud Cabo Huertas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; VITAMIN D;

ADULT; AGED; ARTICLE; ATTITUDE TO ILLNESS; BODY MASS; CALCIUM INTAKE; COMORBIDITY; CONSTIPATION; DIABETES MELLITUS; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; POLYPHARMACY; POSTMENOPAUSE OSTEOPOROSIS; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SELF REPORT; VITAMIN SUPPLEMENTATION;

ANALYSIS OF VARIANCE; CALCIUM; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MEDICATION ADHERENCE; MIDDLE AGED; OBSERVATION; OSTEOPOROSIS, POSTMENOPAUSAL; PRIMARY HEALTH CARE; VITAMIN D;

EID: 70349330807     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/11317070-000000000-00000     Document Type: Article

References (50)

1. Knobel J, Diez A, Arnau D, et al. Secuelas de la fractura de femur osteoporotica en Barcelona. Med Clin (Barc) 1992; 98: 441-444
2. Alvarez-Nebreda ML, Jimenez AB, Rodriguez P, et al. Epidemiology of hip fracture in the elderly in Spain. Bone 2008 Feb; 42 (2): 278-285
3. Altadill Arregui A, Gomez Alonso C, Virgos Soriano MJ, et al. Epidemiologia de la fractura de cadera en Asturias. Med Clin (Barc) 1995; 105: 281-286
4. Herrera A, Martinez AA, Ferrandez L, et al. Epidemiology of osteoporotic hip fractures in Spain. Int Orthop 2006 Feb; 30 (1): 11-14
5. Kanis JA, Torgerson D, Cooper C. Comparison of the European and USA practice guidelines for osteoporosis. Trends Endocrinol Metab 2000; 11: 28-32
6. Grupo de Trabajo de la Sociedad Espanola de Investi- gaciones Oseas y Metabolismo Mineral (SEIOMM). Osteoporosis post-menopausica: guia de practica clinica. Rev Clin Esp 2003; 203: 496-506
7. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281
8. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D and calcium to prevent hip fractures in elderly women. N Eng J Med 1992; 327: 1637-1642
9. Aranceta J, Serra-Majen L, Perez-Rodrigo C, et al. Vitamins in Spanish food patterns: the eVe Study. Public Health Nutr 2001; 4: 1317-1323
10. Ortega RM, Mena MC, Faci M, et al. Vitamin status in different groups of the Spanish population: a meta-analysis of national studies performed between 1990 and 1999. Public Health Nutr 2001; 4: 1325-1329
11. Vaquero MP, Sanchez-Muniz FJ, Carbajal A, et al. Mineral and vitamin status in elderly persons from northwest Spain consuming an Atlantic variant of the Mediterranean diet. Ann Nutr Metab 2004; 48: 125-133
12. Van der Wielen RP, Lowik MR, van den Berg H, et al. Serum vitamin D concentrations among elderly people in Europe. Lancet 1995; 346: 207-210
13. Scharla SH. Prevalence of subclinical vitamin D deficiency in different European countries. Osteoporos Int 1998; 8 Suppl. 2: S7-12
14. Aguado P, del Campo MT, Garces MV, et al. Low vitamin D levels in outpatient postmenopausal women from a rheumatology clinic in Madrid, Spain: their relationship with bone mineral density. Osteoporos Int 2000; 11: 739-744
15. Mezquita Raya P, Munoz Torres M, Lopez Rodriguez F, et al. Elevada prevalencia de deficit de vitamina D en poblaciones con riesgo de osteoporosis: un factor relevante en la integridad osea. Med Clin (Barc) 2002; 119: 85-89
16. Larrosa M, Gratacos J, Vaqueiro M, et al. Prevalencia de hipovitaminosis D en una poblacion anciana institucion-alizada: valoracion del tratamiento sustitutivo. Med Clin (Barc) 2001; 117: 611-614
17. Gomez-Alonso C, Naves-Diaz ML, Fernandez-Martin JL, et al. Vitamin D status and secondary hyperparathyroid-ism: the importance of 25-hydroxyvitamin D cut-off levels. Kidney Int Suppl 2003 Jun; 63: S44-8
18. Quesada JM, Jans I, Benito P, et al. Vitamin D status of elderly people in Spain. Age Ageing 1989; 18: 392-397
19. Gaugris S, Heaney RP, Boonen S, et al. Vitamin D in- adequacy among post-menopausal women: a systematic review. Q J Med 2005; 98: 667-676
20. McCombs JS, Thiebaud P, McLaughlin-Miley C, et al. Compliance with drug therapies for the treatment and prevention of osteoporosis. Maturitas 2004; 48: 271-287
21. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vi- tamin D supplementation and the risk of fractures. N Engl J Med 2006; 354: 669-683 (Pubitemid 43247138)
22. Rizzoli R, Boonen S, Brandi ML, et al. The role of calcium and vitamin D in the management of osteoporosis. Bone 2008 Feb; 42 (2): 246-249
23. Dawson-Hughes B, Harris SS, Krall EA, et al. Effect of with- drawal of calcium and vitamin D supplements on bone mass in elderly men and women. Am J Clin Nutr 2000; 72: 745-750
24. Kripalan S, Yao X, Haynes RB. Interventions to enhance medi- cation adherence in chronic medical conditions: a systematic review. Arch Intern Med 2007 Mar 26; 167 (6): 540-550
25. Gil VF, Belda J, Pineiro F, et al. El incumplimiento en la practica clinica: toma de decisiones diagnosticas y ter-apeuticas. Med Clin (Barc) 2001; 116: 77-87
26. French MR, Vernace-Inserra F, Hawker GA. A prospective study to identify factors affecting adherence to recommended daily calcium intake in women with low bone mineral density. J Am Coll Nutr 2008 Feb; 27 (1): 88-95
27. Argimon JM, Jimenez J. Metodos de investigacion clinica y epidemiologica. Madrid: Elsevier Ed, 2007
28. Sackett DL. Compliance trials and the clinician. Arch Intern Med 1978 Jan; 138 (1): 23-25
29. Sackett DL, Haynes RB, Gibson ES. Randomized clinical trial of strategies for improving medication adherence in primary hypertension. Lancet 1975; 1: 1205-1207
30. Haynes RB, Sackett DL, Gibson ES. Improvement of medication adherence in uncontrolled hypertension. Lancet 1976; 1: 1265-1268
31. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005 Aug 4; 353 (5): 487-497
32. Batalla C, Blanquer A, Ciurana R, et al. Cumplimiento de la prescripcion farmacologica en pacientes hipertensos. Aten Primaria 1984; 1: 185-191
33. Morisky DE, Green LW, Levine DM. Concurrent and pre- dictive validity of a self-reported measure of medication adherence. Med Care 1986; 24: 67-74
34. Pineiro Chousa F, Gil Guillen V, Donis Otero M, et al. Validez de 6 metodos indirectos para valorar el cumpli-miento del tratamiento farmacologico en las dislipemias. Aten Primaria 1997; 19 (9): 465-468
35. Pineiro Chousa F, Gil Guillen V, Donis Otero M, et al. Validez de 6 metodos indirectos para valorar el cumplimiento del tratamiento farmacologico en la hipertension arterial. Aten Primaria 1997; 19 (7): 372-376
36. Caro JJ, Ishak KJ, Huybrechts KF, et al. The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int 2004; 15: 1003-1008
37. Carnevale V, Nieddu L, Romagnoli E, et al. Osteoporosis intervention in ambulatory patients with previous hip fracture: a multicentric, nationwide Italian survey. Osteoporos Int 2006; 17 (3): 478-483
38. Rossini M, Bianchi G, Di Munno O, et al., Treatment of Osteoporosis in clinical Practice (TOP) Study Group. Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int 2006; 17 (6): 914-921
39. Tang BM, Eslick GD, Nowson C, et al. Calcium and vitamin D for osteoporotic fracture risk. Lancet 2007; 370: 657-666
40. Yood RA, Mazor KM, Andrade SE, et al. Patient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefs. J Gen Intern Med 2008 Nov; 23 (11): 1815-1821
41. McHorney CA, Schousboe JT, Cline RR, et al. The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates. Curr Med Res Opin 2007 Dec; 23 (12): 3137-3152
42. Segal E, Tamir A, Ish-Shalom S. Compliance of osteo- porotic patients with different treatment regimens. Isr Med Assoc J 2003 Dec; 5 (12): 859-862
43. Papaioannou A, Kennedy CC, Dolovich L, et al. Patient ad- herence to osteoporosis medications: problems, consequences and management strategies. Drugs Aging 2007; 24: 37-55
44. Reginster JY, Rabenda V. Patient preference in the man- agement of postmenopausal osteoporosis with bisphos-phonates. Clin Interv Aging 2006; 1 (4): 415-423
45. Kendler D, Kung AW, Fuleihan Gel-H, et al. Patients with osteoporosis prefer once weekly to once daily dosing with alendronate. Maturitas 2004 Jul 15; 48 (3): 243-251
46. Lekkerkerker F, Kanis JA, Alsayed N, et al., Group for the Respect of Ethics and Excellence in Science (GREES). Adherence to treatment of osteoporosis: a need for study. Osteoporos Int 2007 Oct; 18 (10): 1311-1317
47. Lau E, Papaioannou A, Dolovich L, et al. Patients? adher- ence to osteoporosis therapy: exploring the perceptions of postmenopausal women. Can Fam Physician 2008 Mar; 54 (3): 394-402
48. Giusti A, Barone A, Razzano M, et al. Persistence with calcium and vitamin D in elderly patients after hip fracture. J Bone Miner Metab 2009; 27 (1): 95-100
49. Boonen S, Rizzoli R, Meunier PJ, et al. The need for clinical guidance in the use of calcium and vitamin D in the management of osteoporosis: a consensus report. Osteoporos Int 2004 Jul; 15 (7): 511-519
50. Cranney A, Horsley T, O?Donnell S, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep) 2007 Aug; 158: 1-235